BIONTECH SE

BNTX

Real-time Estimate - 03/02 11:54:10 am
107.265USD	-2.67%

Turn to zoom

Prev.	110.2100
Open	109.8600
High	109.8600
Low	106.2300
Volume	316 120

8m ago	Merck to Help Johnson & Johnson Make Its Covid-19 Vaccine -- 2nd Update
25m ago	Croda to Benefit from Enlarged Lipid Supply Contract for Pfizer's COVID-19...
1h ago	Merck to help make Johnson & Johnson's COVID-19 vaccine: White House official
2h ago	Merck : to Help J&J Make Its Covid-19 Vaccine, Biden to Announce -- Update

	Short Term	Mid-Term	Long Term
Trend	Bullish	Neutral	Bullish
Resistance	120	130	127
Spread/Res.	-11%	-18%	-16%
Spread/Supp.	-2,4%	84%	46%
Support	109	57,8	73,0

Sales 2020	432 M 519 M 519 M
Net income 2020	-381 M -458 M -458 M
Net cash 2020	836 M 1 005 M 1 005 M
P/E ratio 2020	-57,6x
Yield 2020	-

Capitalization	22 026 M 26 537 M 26 489 M
EV / Sales 2020	49,1x
EV / Sales 2021	2,88x
Nbr of Employees	1 800
Free-Float	90,2%

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including...

>> Read more

Sector :

Bio Therapeutic Drugs

Calendar :

2021-03-02 Presentation

Trading Rating :

Investor Rating :

Mean consensus	OUTPERFORM
Number of Analysts	11
Average target price	94,33 €
Last Close Price	91,48 €
Spread / Highest target	22,7%
Spread / Average Target	3,12%
Spread / Lowest Target	-31,6%